Log In

Trending Across touchCARDIO

At a glance: education, conference reports and articles

CME & Education

Hypertension
touchEXPERT OPINIONS
Medical therapy for CTEPH: From biology to new treatment options
CME ACCREDITED Prof. Irene Lang (Austria), Prof. Marc Humbert (France), Dr Mark Toshner (UK) Watch Time: 30 mins

Watch leading experts involved in the care of patients with CTEPH discuss the latest issues and controversies in the medical management of CTEPH and related comorbidities

Learning objectives
Learning Objectives
  • Describe the biological and pathophysiological mechanisms of CTEPH
  • Summarize the evolving data supporting the use of oral therapies
  • Explain how new developments in medical therapy for the treatment of CTEPH will change daily practice
4 months ago
View All

Conference Hub

Atrial fibrillation
Atrial Fibrillation Association Global AF Aware Week – Karen Glover Presentation

Dr Karen Glover gives her award winning AF Association Healthcare Pioneer project on advancing atrial fibrillation diagnosis and management in the East Midlands. Filmed at the AF Association Global AF Aware Week Parliamentary Event, November 2019 in partnership with Atrial Fibrillation Association.

7 months ago
View All

Learning Zone

Cardiovascular Risk
touchEXPERT BRIEFING
Updates and new guidelines in statin therapy
Prof. Alberico Catapano (Italy), Dr Alan Brown (USA), Prof. Kausik Ray (UK) Watch Time: 25 mins

Watch clinical specialists from Europe and the USA discuss techniques for the management and treatment of patients with high LDL-C levels, recorded during the ESC Congress 2019, Paris, France.

Learning objectives
Learning Objectives
  • Understand the importance of the ACC/AHA 2018 and ESC 2019 guidelines for management of blood cholesterol/dyslipidaemias with respect to clinical practice
  • Know the risks and benefits of statin treatment with respect to the risk for type 2 diabetes
  • Understand the potential for abnormal liver function and metabolic syndrome and be aware of drug-drug interaction as most statins are metabolized via the cytochrome P450 pathway
  • Know that the PROVE IT and REAL-CAD trials show that high-dose statin therapy is superior to moderate or low dose in cardiovascular event reduction
  • Understand that combination therapy gives an additional reduction in LDL levels and that statin dose should be titrated to risk
2 months ago
View All

Journal Articles

Cardiovascular disease
Persistent Myocardial Ischaemia due to Anaemia in a Patient with Coeliac Disease – A Case Report
Aleksandra Gąsecka, Karolina Kruk, Adam Przybyłkowski, Tomasz Mazurek, Janusz Kochman, Krzysztof J Filipiak

Heart International. 2020;14(1): Online ahead of journal publication

Coeliac disease (CD) is a systemic disease of inappropriate immune response to gluten, which affects up to 1% of the population in the Western world.1 Gluten proteins are found in dietary products containing wheat, rye, barley and related grains. In patients who carry the human leukocyte antigen (HLA)-DQ2 and HLA-DQ8 alleles of the major histocompatibility […]

4 weeks ago
View All

More From CME & Education

View All

Learn more from touchCARDIO with CME-accredited and independent learning activities

Hypertension
CME ACCREDITED
touchEXPERT OPINIONS
Medical therapy for CTEPH: From biology to new treatment options
Prof. Irene Lang (Austria), Prof. Marc Humbert (France), Dr Mark Toshner (UK) Watch Time: 30 mins

Watch leading experts involved in the care of patients with CTEPH discuss the latest issues and controversies in the medical management of CTEPH and related comorbidities

Learning objectives
Learning Objectives
  • Describe the biological and pathophysiological mechanisms of CTEPH
  • Summarize the evolving data supporting the use of oral therapies
  • Explain how new developments in medical therapy for the treatment of CTEPH will change daily practice
4 months ago

    • More From The Conference Hub

    View All

    View highlights and coverage from leading international Cardio congresses

    More From Learning Zone

    View All

    Medical education and communication on key topics in the area of Cardio. Content in this section is sponsored by the pharmaceutical industry.

    Cardiovascular Risk
    touchEXPERT BRIEFING
    Updates and new guidelines in statin therapy
    Prof. Alberico Catapano (Italy), Dr Alan Brown (USA), Prof. Kausik Ray (UK) Watch Time: 25 mins

    Watch clinical specialists from Europe and the USA discuss techniques for the management and treatment of patients with high LDL-C levels, recorded during the ESC Congress 2019, Paris, France.

    Learning objectives
    Learning Objectives
    • Understand the importance of the ACC/AHA 2018 and ESC 2019 guidelines for management of blood cholesterol/dyslipidaemias with respect to clinical practice
    • Know the risks and benefits of statin treatment with respect to the risk for type 2 diabetes
    • Understand the potential for abnormal liver function and metabolic syndrome and be aware of drug-drug interaction as most statins are metabolized via the cytochrome P450 pathway
    • Know that the PROVE IT and REAL-CAD trials show that high-dose statin therapy is superior to moderate or low dose in cardiovascular event reduction
    • Understand that combination therapy gives an additional reduction in LDL levels and that statin dose should be titrated to risk
    2 months ago

    Latest Journal Articles

    View All

    Read the latest articles from our peer reviewed Cardio journals published by touchCARDIO

    Cardiovascular disease
    Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial?
    Andre Briosa e Gala, Nick Curzen

    Heart International. 2020;14(1):Online ahead of journal publication.

    Optimal medical therapy (OMT) is the cornerstone of management in patients with coronary atheroma, given the substantial evidence that it can delay disease progression and damp down both chronic and acute vascular inflammation, thereby leading to a reduction in cardiovascular events and mortality.1,2 In this context, revascularisation, with either percutaneous coronary intervention (PCI) or coronary […]

    5 days ago
    Interventional cardiology
    The Coronary Sinus Reducer – Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina
    Carlo Zivelonghi, Stefan Verheye

    Heart International. 2020;14(1):Online ahead of journal publication

    Refractory angina pectoris is a chronic disabling condition affecting an increasing number of patients (10–15%) with severe ischaemic heart disease.1 It is generally defined as the presence of debilitating angina due to severe and/or diffuse coronary artery disease (CAD), despite optimal medical therapy and with no option for further percutaneous or surgical revascularisation procedures. As […]

    1 week ago
    Cardiovascular disease
    Persistent Myocardial Ischaemia due to Anaemia in a Patient with Coeliac Disease – A Case Report
    Aleksandra Gąsecka, Karolina Kruk, Adam Przybyłkowski, Tomasz Mazurek, Janusz Kochman, Krzysztof J Filipiak

    Heart International. 2020;14(1): Online ahead of journal publication

    Coeliac disease (CD) is a systemic disease of inappropriate immune response to gluten, which affects up to 1% of the population in the Western world.1 Gluten proteins are found in dietary products containing wheat, rye, barley and related grains. In patients who carry the human leukocyte antigen (HLA)-DQ2 and HLA-DQ8 alleles of the major histocompatibility […]

    4 weeks ago
    Cardiovascular disease, Congenital conditions
    A Rare Case of Cor Triatriatum Sinister in Adulthood with Atypical Manifestation
    Thauler Alves de Oliveira, Renan Attílio Santos Marquiori

    Heart International. 2020;14(1):Online ahead of journal publication

    First described in 1868 by WS Church, cor triatriatum sinister (CTS) is one of the rarest congenital heart diseases in the world, with an estimated incidence of 0.1%.1,2 It is characterised by the presence of a fibrous membrane that divides the left atrium into two different regions: a proximal chamber with the pulmonary veins and […]

    4 weeks ago

    Want To Know More About Our Journals?

    Taking a balanced and practical view of the current clinical landscape in Cardio is at the heart of touchCARDIO and the journals we produce.

    The European Journal of Arrhythmia & Electrophysiology and Heart International are double-blind peer reviewed by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the day-to-day clinical setting.

    Learn more about our journals

    Society & Congress Partners

    View All

    touchCARDIO is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

    Journal articles and more to your inbox

    Get the latest clinical insights from touchCARDIO

    Sign me up!
    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowlinkmenumore_dots padlock person play-colourAsset 1podcastprinter search share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrow